Moderna begins trial of Omicron-specific vaccine booster

Inquirer.net 01/27/2022

WASHINGTON – US biotech company Moderna announced on Wednesday, January 26, 2022, that it has begun clinical trials of a booster dose of vaccine designed specifically to combat the Omicron variant of the coronavirus. The trials will…

In Oslob, adolescents to get COVID vaccines this November

Morexette Marie B. Erram 11/03/2021

CEBU CITY, Philippines – Young adults in Oslob town in southern Cebu may get their COVID-19 vaccine shots this month. This after the town’s Rural Health Unit (RHU) announced that they are aiming to start inoculation of…

Vaccination of minors with co-morbidities in Cebu City starts on Oct. 29

Delta Dyrecka Letigio 10/28/2021

  CEBU CITY, Philippines — Cebu City will begin the vaccination for minors with comorbidities tomorrow, October 29, 2021.  City Health Officer-in-charge, Doctor Jeffrey Ibones, said that they would hold a ceremonial launch at the Vicente Sotto…

Lapu-Lapu has masterlisted 4K minors for vaccination

Futch Anthony Inso 10/07/2021

LAPU-LAPU CITY, Philippines — The Lapu-Lapu City government has already masterlisted 4,000 minors, whose ages are 12-17 years old, to be inoculated with the coronavirus disease 2019 (COVID-19) vaccines. Lawyer James Sayson, deputy chief of the Local…

Vaccinated pregnant women pass protective antibodies to babies

Reuters 09/26/2021

Pregnant women who get an mRNA vaccine against COVID-19 pass high levels of protective antibodies on to their babies, new research shows. Doctors analyzed umbilical cord blood from 36 newborns whose mothers had received at least one…

Cebu City eyes creating separate vaccine registration site for adolescents

Morexette Marie B. Erram 09/06/2021

CEBU CITY, Philippines — Cebu City is planning to create a separate registration site for adolescents who will be qualified to receive free COVID-19 vaccines from the government. Local officials here welcomed the decision of the Food…

Moderna gets FDA approval for use on 12-17 age group

09/04/2021

The Food and Drug Administration (FDA) has approved the emergency use of the Moderna COVID-19 vaccine on children age 12 to 17. The Department of Health (DOH), however, has yet to give the go signal for the…

FDA OKs emergency use of Moderna vaccine on adolescents aged 12 to 17

Daphne Galvez 09/03/2021

  MANILA, Philippines — The Food and Drug Administration (FDA) has allowed the emergency use of the Moderna COVID-19 vaccine on adolescents who are 12 to 17 years old. FDA Director-General Eric Domingo on Friday, September 2,…

That mad scramble for Pfizer vaccine

Ma. Ceres P. Doyo - @inquirerdotnet 05/27/2021

What did people’s mad scramble last week for the US-manufactured Pfizer vaccine tell us? But first, thank God it did not turn out to be a killer stampede reminiscent of TV’s live show “Wowowee” in 2006 that…

Moderna COVID-19 vaccine gets emergency use authorization

Daphne Galvez 05/05/2021

MANILA, Philippine — The COVID-19 vaccine of American pharmaceutical firm Moderna has been granted an emergency use authorization (EUA), the Food and Drug Administration said Wednesday. FDA Director General Eric Domingo said the agency only took about…

Incompetence in the first degree

Solita Collas-Monsod - @inquirerdotnet 04/17/2021

As I write this column, I am preparing to go to our village vaccine center and be vaccinated against COVID-19. I am loathe to do so, because the administered vaccine is Sinovac, which is not even part…

Mandaue firms eye vaccine shots for 50K workers

Mary Rose Sagarino 03/25/2021

MANDAUE CITY, Philippines — About 50,000 employees in Mandaue City will soon be vaccinated against the coronavirus disease 2019 (COVID-19). Steven Yu, Mandaue Chamber of Commerce and Industry (MCCI) president, said they were expecting at least 100,000…

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.